Nullary vs. Open Pharma data sources
TLDR
- “Open pharma” refers to the ecosystem of open public databases (ChEMBL, PubChem, DepMap, FLAb, ClinicalTrials.gov, and others) maintained by academic institutions and governments
- Nullary aggregates 25+ of these sources into a unified MCP-queryable layer
- Open Pharma sources are individually free but require separate integrations, schema mappings, and update tracking per source
- Nullary handles the integration, normalization, and freshness so you can query across all of them in seconds
What each provides
Open Pharma databases (individually):
- ChEMBL — small-molecule bioactivity
- PubChem BioAssay — compound screening outcomes
- DepMap — CRISPR essentiality screens
- FLAb — antibody developability
- SAbDab — antibody structures
- ClinicalTrials.gov — clinical trial registrations
- AACT — relational version of ClinicalTrials.gov
- EudraCT — European clinical trials
- Drugs@FDA — drug approval status
- PROTAC-DB — PROTAC activity
- THPdb — therapeutic peptides
- AOBase — antisense oligonucleotides
- (and others)
Nullary integrates all of the above (plus more) with:
- Unified schema across modalities
- Full source provenance per record
- MCP-native query interface
- REST API
- Alerts and webhooks (Standard tier)
- Analytics suite (Premium tier)
- Agent-curated deep extractions (Enterprise tier)
When to use the underlying open sources directly
- You need raw bulk data without integration overhead is acceptable
- You have an existing pipeline that already integrates 5+ of these sources
- You need source-specific features that Nullary doesn't surface (e.g., DepMap's full per-cell-line gene effect matrices)
- You're an academic researcher with no budget for paid tools
When to use Nullary
- You're building agent workflows that need negative-results data across modalities
- You don't want to maintain integrations to 25+ databases yourself
- You want cross-modality queries that no individual database supports
- You want alerts and analytics layered on top of the raw data
- Your time is more valuable than the $49-499/mo subscription
Pricing comparison
All the underlying open-pharma databases are free for individual use. Nullary's free tier is also free and provides MCP access across all modalities. Paid tiers ($49 yearly / $79 monthly Standard; $299 yearly / $499 monthly Premium) add capabilities that the underlying databases don't provide individually.
Bottom line
Nullary is the open-pharma ecosystem unified into one queryable layer. Use Nullary when integration time, cross-modality queries, alerts, or analytics matter more than the cost of a subscription. Use the underlying databases directly when you need their specific features or you have an existing integration.